29 related articles for article (PubMed ID: 27342497)
21. [Prognostic Value of Morphology and Hans Classification in Diffuse Large B Cell Lymphoma].
Wang KL; Chen C; Shi PF; Yu JH; Tan JF; Qian SX; Gao DQ; Chen K; Liu LR; Xie YP; Xu Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):1079-1085. PubMed ID: 30111411
[TBL] [Abstract][Full Text] [Related]
22. [Expression and clinical significance of Ki-67 in diffuse large B cell lymphoma].
Zhou Y; Zhao Y; Bo J; Li YF; Ma C; Shi YN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1162-6. PubMed ID: 24156426
[TBL] [Abstract][Full Text] [Related]
23. [The clinical characteristics of 681 patients with diffuse large B-cell lymphoma].
Wen JJ; Liu ZB; Xu J; Xu CG
Zhonghua Xue Ye Xue Za Zhi; 2012 Dec; 33(12):1004-9. PubMed ID: 23363791
[TBL] [Abstract][Full Text] [Related]
24. [Expression of dendritic cell marker CD21 is a positive prognostic factor in diffuse large B-cell lymphoma].
Yao WK; Wang YP; Peng F; Zheng Y; Zou YB; Gao JN; Liu XL
Zhonghua Bing Li Xue Za Zhi; 2012 Dec; 41(12):818-22. PubMed ID: 23324230
[TBL] [Abstract][Full Text] [Related]
25. [Expression of CD30 in Diffuse Large B Cell Lymphoma and Its Clinical Significance].
Zhao YF; Qian SX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):717-21. PubMed ID: 27342497
[TBL] [Abstract][Full Text] [Related]
26. An overview of the correlation between IPI and prognosis in primary breast lymphoma.
Feng K; Zhao S; Shang Q; Liu J; Yang C; Ren F; Wang X; Wang X
Am J Cancer Res; 2023; 13(1):245-260. PubMed ID: 36777506
[TBL] [Abstract][Full Text] [Related]
27. Practical Approaches on CD30 Detection and Reporting in Lymphoma Diagnosis.
Xu ML; Gabali A; Hsi ED; Fedoriw Y; Vij K; Salama ME; Ramchandren R; O'Malley D; Wick MR; Battistella M; Gru AA
Am J Surg Pathol; 2020 Feb; 44(2):e1-e14. PubMed ID: 31567279
[TBL] [Abstract][Full Text] [Related]
28.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
29.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]